Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma
- 25 June 2015
- journal article
- review article
- Published by Springer Nature in Hepatology International
- Vol. 9 (4) , 514-519
Abstract
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. Curative treatments for early-stage HCC include local ablation, hepatic resection, and liver transplant. Radiofrequency ablation (RFA) is a minimally invasive treatment and can be used in patients who have an increased risk of hepatic resection, including a liver reserve of Child-Pugh B status and suboptimal general condition. However, a difficult location of HCC can interfere with the performance of RFA because of a conspicuous lesion, poor electrode path, or increased risk of thermal injury to adjacent organs. Difficult locations include tumors abutting the diaphragm or near vital organs such as the gastrointestinal tract and gallbladder. Because artificial ascites can provide an improved sonic view and protects adjacent vital organs from thermal injury, it widens the indication of RFA in the treatment of HCC. The systemic review showed that the technique of artificial ascites has a high success rate (>90 %) without the clear appearance of severe adverse events such as intraperitoneal hemorrhage or gastrointestinal perforation. The risk of intraperitoneal seeding is not increased. In addition, the therapeutic effectiveness, such as the complete ablation rate or local tumor progression rate, remains satisfactory for difficult-to-ablate HCCs. In conclusion, RFA after infusion of artificial ascites is feasible and effective for difficult-to-ablate HCCs. However, because data on the local tumor progression rate, heat-sink effect, and intraperitoneal seeding are scarce, additional studies are required.Keywords
Funding Information
- Research Department of Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- The Ministry of Science and Technology and Ministry of Health and Welfare, Executive Yuan, Taiwan, and the National Taiwan University Hospital, Taiwan.
This publication has 30 references indexed in Scilit:
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJournal of Hepatology, 2012
- Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinomaWorld Journal of Surgical Oncology, 2012
- Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinomaBMC Gastroenterology, 2010
- Radiofrequency Ablation for Hepatocellular Carcinoma: Assistant Techniques for Difficult CasesOncology, 2010
- Local Ablation for Hepatocellular Carcinoma in Taiwan: Different Points between Japan, Asia and WestOncology, 2010
- Percutaneous Radiofrequency Ablation for Hepatic Tumors Abutting the Diaphragm: Clinical Assessment of the Heat-Sink Effect of Artificial AscitesAmerican Journal of Roentgenology, 2010
- EFFICACY OF LAPAROSCOPIC RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA COMPARED TO PERCUTANEOUS RADIOFREQUENCY ABLATION WITH ARTIFICIAL ASCITESDigestive Endoscopy, 2009
- Percutaneous Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in the Hepatic Dome: Initial ExperienceAmerican Journal of Roentgenology, 2008
- Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascitesJournal of Gastroenterology, 2007
- Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tractBritish Journal of Surgery, 2006